Strategic Investment Solutions’s AbbVie ABBV Stock Holding History

Strategic Investment Solutions’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$49.1K	Buy	195 +23	+13%	+$4.95K	0.01%	264
2026 Q1	$37.4K	Buy	172 +6	+4%	+$1.33K	0.01%	282
2025 Q4	$37.8K	Buy	166 +1	+0.6%	+$228	0.01%	265
2025 Q3	$38.1K	Sell	165 -23	-12%	-$4.68K	0.01%	241
2025 Q2	$34.9K	Sell	188 -1,631	-90%	-$303K	0.01%	245
2025 Q1	$381K	Sell	1,819 -517	-22%	-$101K	0.11%	77
2024 Q4	$374K	Buy	2,336 +534	+30%	+$98.2K	0.13%	77
2024 Q3	$356K	Sell	1,802 -72	-4%	-$13.4K	0.11%	79
2024 Q2	$329K	Buy	+1,874	New	+$310K	0.11%	76
2023 Q4	$323K	Sell	2,085 -14,057	-87%	-$2.05M	0.06%	142
2023 Q3	$2.37M	Buy	16,142 +15,888	+6,255%	+$2.33M	0.03%	209
2023 Q2	$34K	Sell	254 -2,062	-89%	-$302K	0.01%	367
2023 Q1	$369K	Buy	2,316 +17	+0.7%	+$2.6K	0.07%	127
2022 Q4	$333K	Buy	+2,299	New	+$353K	0.16%	68

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Strategic Investment Solutions's ABBV Position: Q2 2026 in Review

Strategic Investment Solutions increased its AbbVie (ABBV) stake by 13% in Q2 2026, buying an estimated $4.95K and bringing the position to 195 shares worth $49.1K. The position accounts for 0.01% of the portfolio, ranked #264.

Strategic Investment Solutions first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.37M in Q3 2023. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Strategic Investment Solutions held 195 shares of AbbVie worth $49.1K as of Q2 2026.
Strategic Investment Solutions bought 23 AbbVie shares in Q2 2026, an estimated $4.95K.
AbbVie made up 0.01% of Strategic Investment Solutions's portfolio in Q2 2026, its #264 holding.
Strategic Investment Solutions first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
Strategic Investment Solutions's AbbVie position peaked at $2.37M in Q3 2023.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Strategic Investment Solutions's 13F filing for Q2 2026, filed 8 Jul 2026.